AKT2 Antikörper

Produktnummer ABIN1724720

Produktdetails anti-AKT2 Antikörper

Target: AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser AKT2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunocytochemistry (ICC)

Verwendungszweck: AKT2 Antibody

Aufreinigung: Ascitic fluid

Immunogen: Purified recombinant fragment of human AKT2 expressed in E. Coli.

Klon: 1B6

Isotyp: IgG2b

Anwendungsinformationen

Applikationshinweise:

ELISA: 1/10000

ICC: 1/200 - 1/1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Ascitic fluid containing 0.03 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Referenzen für anti-AKT2 Antikörper (ABIN1724720)

Gosmanov, Umpierrez, Karabell, Cuervo, Thomason: "Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes." in: American journal of physiology. Endocrinology and metabolism, Vol. 287, Issue 1, pp. E8-E15, (2004) (PubMed).

Xu, Sakon, Nagano, Hiraoka, Yamamoto, Hayashi, Dono, Nakamori, Umeshita, Ito, Matsuura, Monden: "Akt2 expression correlates with prognosis of human hepatocellular carcinoma." in: Oncology reports, Vol. 11, Issue 1, pp. 25-32, (2003) (PubMed).

Details zu AKT2

Target: AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))

Andere Bezeichnung: AKT2 (AKT2 Produkte)

Synonyme: AKT2 antikoerper, pkbb antikoerper, pkbbeta antikoerper, pkbss antikoerper, prkbb antikoerper, rac-beta antikoerper, v-akt2 antikoerper, 2410016A19Rik antikoerper, AW554154 antikoerper, PKB antikoerper, PKBbeta antikoerper, HIHGHH antikoerper, PKBB antikoerper, PKBBETA antikoerper, PRKBB antikoerper, RAC-BETA antikoerper, cb945 antikoerper, akt2-a antikoerper, AKT serine/threonine kinase 2 antikoerper, v-akt murine thymoma viral oncogene homolog 2 antikoerper, thymoma viral proto-oncogene 2 antikoerper, v-akt murine thymoma viral oncogene homolog 2 L homeolog antikoerper, AKT2 antikoerper, akt2 antikoerper, Akt2 antikoerper, akt2.L antikoerper

Hintergrund:

Description: Akt2 (also designated protein kinase B beta or v-akt murine thymoma viral oncogene homolog 2 ), with 481-amino acid protein (about 53 kDa), belongs to the AKT serine/threonine protein kinase family, which also includes Akt1 and Akt3. They are involved in a wide variety of biological processes including cell proliferation, differentiation, apoptosis, tumorigenesis, as well as glycogen synthesis and glucose uptake. Among the members of AKT family, Akt2 is associated with the development of human cancers. Akt2 inhibits cisplatin-induced JNK/p38 and Bax activation through phosphorylation of ASK1 and thus, plays an important role in chemoresistance. Further, Akt2 plays a specific role in muscle differentiation.

Aliases: PKBB, PRKBB, PKBBETA, RAC-BETA

Molekulargewicht: 60kDa

Gen-ID: 208

HGNC: 208

UniProt: P31751

Pathways: PI3K-Akt Signalweg, RTK Signalweg, AMPK Signaling, TLR Signalweg, Cellular Glucan Metabolic Process, Regulation of Carbohydrate Metabolic Process, Hepatitis C, VEGF Signaling